Toxocara and Toxocariasis, Volume 109 in the Advances in Parasitology series, includes medical studies of parasites of major influence, along with reviews of more traditional areas, such as zoology, taxonomy and life history, all topics which help to shape current thinking and applications. This latest release includes chapters on organism and the recognition of the disease, dogs (and cats) disease, diagnosis, prevalence of infection, and treatment, and more.
PART I - The organism and the recognition of the disease 1. Toxocara: Protecting pets and improving the lives of people 2. History of Toxocara and the associated larva migrans 3. The anatomy of the third-stage larva of Toxocara canis and Toxocara cati 4. Visceral larval migrans of Toxocara canis and Toxocara cati in non-canid and non-felid hosts 5. Toxocara “omics and the promises it holds for medicine and veterinary medicine PART II - The effects of infection, host response to infection, diagnosis, and treatment of people 6. Toxocariasis and the clinical spectrum 7. Serodiagnostic methods for diagnosing larval toxocariasis 8. Clinical pathology of larval toxocariasis 9. Imaging of toxocariasis 10. Toxocara-induced neural larva migrans (neurotoxocarosis) in rodent model hosts 11. Neurotoxocariasis 12. Pathogenesis of cerebral toxocariasis and neurodegenerative diseases 13. Neurocognitive and neuropsychiatric effects of toxocariasis PART III – Epidemiology 14. Global and regional seroprevalence estimates for human toxocariasis: A call for action 15. Toxocara seroprevalence in Canada—Climate, environment and culture 16. Toxocara seroprevalence in the USA and its impact for individuals and society 17. Toxocara: Seroprevalence in Mexico 18. Seroprevalence Brazil 19. Seroprevalence of human toxocarosis in Europe: A review and meta-analysis 20. Seroprevalence and incidence of human toxocarosis in Russia 21. Current epidemic situation of human toxocariasis in China 22. Seroprevalence of Toxocara spp. infection in Southeast Asia and Taiwan 23. Sources and seroprevalence of toxocariasis in Turkey 24. Seroprevalence of Toxocara spp. antibodies in humans in Africa: A review 25. Seroepidemiology of human toxocariasis in North Africa PART IV - Dogs (and cats) disease, diagnosis, prevalence of infection, and treatment 26. Pathology of larvae and adults in dogs and cats 27. Antigen detection: Insights into Toxocara and other ascarid infections in dogs and cats 28. Global prevalence of Toxocara infection in dogs 29. Sources of environmental contamination with Toxocara spp.: An omnipresent parasite 30. Global prevalence of Toxocara infection in cats 31. Toxocara spp. in dogs and cats in Canada 32. Toxocara canis and Toxocara cati in domestic dogs and cats in the United States, Mexico, Central America and the Caribbean: A review 33. Toxocara prevalence in dogs and cats in Brazil 34. Prevalence of Toxocara spp. in dogs and cats in South America (excluding Brazil) 35. Prevalence of patent Toxocara spp. infections in dogs and cats in Europe from 1994 to 2019 36. Toxocara prevalence in dogs, cats and the environment in Russia 37. Canine Toxocariosis: Its prevalence, incidence and occurrence in the Indian subcontinent 38. Epidemiology of Toxocara spp. in dogs and cats in mainland China, 2000–2019 39. Prevalence of Toxocara in dogs and cats in Africa 40. Toxocara canis in Australia 41. Toxocariasis: A neglected infection for the Anthropocene epoch
Dr. Bowman is a Professor in the Department of Microbiology and Immunology, Cornell University, NY, and has been associated with the department since 1987 (previously an assistant professor,1987-1993). He received the MS degree in Parasitology from Tulane University in 1976. He then received his PhD from Tulane University in 1983 studying Parasitology. He has held successive positions at Cornell University since 1987. He has obtained continuous funding (corporate and federal) throughout his career to study animal parasitology.
